Platform
Features
Pricing
1 follower
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.
Industries
Headquarters
Employees
Links
10 members
7 members
3 members
Synthekine
3 followers
Forge Biologics
2 followers
Ensoma
Entos
CG Oncology
Anthos Therapeutics
Generate Biomedicines
Cellares
ACELYRIN
Nuvalent
Thermo Fisher Scientific
182 followers
Explore companies